All news articles for September 2022

© Jomkwan / Getty Images

GSK picks up antibiotic in $66m deal

By Ben Hargreaves

GSK pays for the exclusive license of Spero‘s late-stage antibiotic to potentially treat complicated urinary tract infections.

© franckreporter / Getty Images

Takeda signs 12-year renewable energy agreement in US

By Ben Hargreaves

Adding to broader action being taken across the industry, the company has signed an agreement with Enel for the supply of renewable energy credits covering its electricity needs across the US.

© VeranoVerde / Getty Images

Exagen on why AVISE test can end the ‘diagnostic odyssey’

Autoimmune diagnostics life sciences company Exagen is heralding the completion of the CAPSTONE study as evidence that its AVISE Lupus test is more clinically effective than traditional ANA methods (tANA), benefiting patients, providers and payers by...

(Iuliia Kanivets/iStock via Getty Images Plus)

CVS Health agrees to acquire Signify Health

By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

(royyimzy/iStock via Getty Images Plus)

People on the Move: September 2022

By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Follow us


View more